ZLAB

Zai Lab Limited

Price

$24.31

return (12m)

-29.41%

p/e

-150.44

p/bv

46.65

DIVIDEND YIELD

0.00%

ZLAB price

Zai Lab

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ZLAB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.97%

3 months

27.14%

1 year

-29.41%

2 years

-2.21%

5 years

-76.34%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ZLAB

Valuation

P/E

-150.44

Sector -3.50

Industry -3.50

P/BV

46.65

Sector 1.98

Industry 1.98

P/Revenue (PSR)

62.98

Sector 2.03

Industry 2.03

EV/EBITDA

-600.99

Sector -216.72

Industry -216.72

EV/EBIT

-551.09

Sector -46.47

Industry -46.47

P/EBITDA

-167.74

Sector -21.39

Industry -21.39

P/EBIT

-153.27

Sector -27.84

Industry -27.84

P/Total Assets

26.34

Sector 1.16

Industry 1.16

P/Net Current Assets

63.45

Sector -10.64

Industry -10.64

P/Working Capital

58.33

Sector -139.65

Industry -139.65

EPS

-0.17

Sector -1.78

Industry -1.78

BVPS

0.54

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

56.51%

Sector 41.35%

Industry 41.35%

EBITDA Margin

-43.35%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-47.28%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

-58.74%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-41.86%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

-31.01%

Sector -57.40%

Industry -57.40%

ROA

-17.51%

Sector -59.44%

Industry -59.44%

ROIC

-76.51%

Sector -2,370.21%

Industry -2,370.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.13

Sector 2.91

Industry 2.91

Net Debt / EBITDA

13.40

Sector -21.98

Industry -21.98

Net Debt / EBIT

12.29

Sector -8.44

Industry -8.44

Net Debt / Equity

-1.02

Sector -33,112.99

Industry -33,112.99

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.56

Sector 0.46

Industry 0.46

Liabilities/Assets

0.44

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

25.52%

Sector -

Industry -

5Y Earnings CAGR

-23.20%

Sector -

Industry -

Fundamentals ZLAB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ZLAB Zai Lab Limited	$24.31	-29.41%	0.00%	-150.44	46.65	-31.01%	-41.86%
PFE Pfizer Inc.	$27.48	8.11%	6.08%	37.23	1.89	5.07%	6.80%
ABBV AbbVie Inc.	$259.97	9.77%	2.60%	73.78	-78.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$37.23	-33.47%	4.80%	9.44	5.02	53.11%	35.32%
MRK Merck & Co. Inc.	$143.18	65.09%	2.29%	114.37	8.64	7.56%	4.77%
AZN AstraZeneca PLC	$156.59	-4.79%	1.95%	19.85	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.33	34.57%	4.09%	13.50	5.62	41.59%	18.87%
ZTS Zoetis Inc.	$69.46	-51.82%	2.99%	11.07	9.27	83.77%	27.69%
AMGN Amgen Inc.	$402.15	38.44%	2.43%	25.29	18.92	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$729.88	22.13%	0.47%	18.75	2.56	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$108.98	45.42%	0.00%	32.57	93.84	288.13%	24.86%
MCK McKesson Corporation	$888.29	16.56%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$501.27	24.01%	0.00%	30.03	6.53	21.76%	35.00%
CAH Cardinal Health Inc.	$226.17	45.05%	0.93%	30.18	-18.99	-62.92%	0.67%
ARGX argenx SE	$914.13	19.13%	0.00%	24.66	6.43	26.07%	25.78%
HRMY Harmony Biosciences Holdings Inc.	$39.41	46.40%	0.00%	13.11	2.38	18.14%	18.88%
BIIB Biogen Inc.	$220.34	42.87%	0.00%	39.95	1.77	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ZLAB - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Zai Lab

Zai Lab Limited

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2017

Time since IPO - 9 years

1.784

Employees

Zai Lab Limited (United States) is listed on the Nasdaq and has a market capitalization of $28.32 billion, with shareholders equity totaling $607.04 million.

The company employs approximately 1.784 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Zai Lab Limited reported $449.61 million in revenue, generating net income of $-188.21 million.

Key financial metrics include a P/E ratio of -150.44, a price-to-book (P/B) ratio of 46.65, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ZLAB.

Market cap

$28.32 billion

Net worth

$607.04 million

$607,037,000.00

Assets

$1.07 billion

$1,074,793,000.00

Total Shares Outstanding

1.12 billion

1,116,973,000

Average Daily Trading Volume

$974.52 Thousand

$974,524.00

Sector

Health Care

Industry

Biotechnology

ZLAB

ZLAB revenue and profits

Financial Results ZLAB

DRAG THE FRAME TO SEE MORE DATA

ZLAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$888.29 17,54% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$226.17 44,56% (12M)

P/E

30.18

0.93%

ROE

-62.92%

P/BV

-18.99

ABBV - AbbVie

$259.97 13,40% (12M)

P/E

73.78

2.60%

ROE

-106.44%

P/BV

-78.53

MRK - Merck & Co.

$143.18 66,23% (12M)

P/E

114.37

2.29%

ROE

7.56%

P/BV

8.64

AZN - AstraZeneca

$156.59 --6,64% (12M)

P/E

19.85

1.95%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.48 8,62% (12M)

P/E

37.23

6.08%

ROE

5.07%

P/BV

1.89

BMY - Bristol-Myers Squibb

$60.33 39,57% (12M)

P/E

13.50

4.09%

ROE

41.59%

P/BV

5.62

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$888.29 17,54% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$226.17 44,56% (12 M)

P/L

30.18

0.93%

ROE

-62.92%

P/VP

-18.99

ABBV - AbbVie

$259.97 13,40% (12 M)

P/L

73.78

2.60%

ROE

-106.44%

P/VP

-78.53

MRK - Merck & Co.

$143.18 66,23% (12 M)

P/L

114.37

2.29%

ROE

7.56%

P/VP

8.64

AZN - AstraZeneca

$156.59 --6,64% (12 M)

P/L

19.85

1.95%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.48 8,62% (12 M)

P/L

37.23

6.08%

ROE

5.07%

P/VP

1.89

BMY - Bristol-Myers Squibb

$60.33 39,57% (12 M)

P/L

13.50

4.09%

ROE

41.59%

P/VP

5.62

Frequently Asked Questions

What is the price of Zai Lab (ZLAB) today?

The current price of Zai Lab (ZLAB) is $24.31. The stock began the year trading around $17.64 and is currently priced at $24.31. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Zai Lab (ZLAB) pay dividends?

Zai Lab (ZLAB) did not pay dividends over the past year.

Is Zai Lab (ZLAB) a good investment?

Zai Lab (ZLAB) is currently trading at $24.31 with a P/E ratio of -150.44. This represents a -10,256% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -29.41%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Zai Lab (ZLAB) stock?

You can buy Zai Lab (ZLAB) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ZLAB and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Zai Lab (ZLAB) yield today?

Over the past month, Zai Lab (ZLAB) has returned -6.97% — -29.41% over the past year, and -76.34% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Zai Lab (ZLAB) today at the current price of $24.31 your total investment would be $2,431.00.

Based on historical performance, the investment would have grown to approximately:

$1,716.04 after 1 year
$575.17 after 5 years
$2,431.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ZLAB

Zai Lab Limited

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ZLAB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ZLAB WITH OTHER STOCK

ABOUT Zai Lab

Zai Lab Limited

United States

13 years

2017

1.784

PROFIT X PRICE ZLAB

Financial Results ZLAB

ZLAB cash flow

Asset, Revenue and Profit Growth - ZLAB

ZLAB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions